Newsroom | 40696 results
Sorted by: Latest
-
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer...
-
Samenvatting: Carnegie Mellon University en Cleveland Clinic ontwikkelen AI-systeem voor nauwkeurigere interpretatie van MRI-scans van het hart
PITTSBURGH & CLEVELAND--(BUSINESS WIRE)--Een team van onderzoekers van Carnegie Mellon University heeft in samenwerking met het Cardiovascular Innovation Research Center van de Cleveland Clinic een systeem met kunstmatige intelligentie (AI) ontwikkeld dat enkele van de meest complexe hartscans in de geneeskunde, namelijk MRI-scans van het hart, kan interpreteren zonder dat er handmatig gelabelde trainingsgegevens nodig zijn. Het nieuwe systeem, genaamd CMR-CLIP, is ontworpen om MRI-scans van he...
-
Riassunto: Carnegie Mellon University e Cleveland Clinic sviluppano un sistema IA per l'interpretazione delle risonanze magnetiche cardiache con una precisione superiore
PITTSBURGH e CLEVELAND--(BUSINESS WIRE)--Un team di ricercatori della Carnegie Mellon University, in collaborazione con il centro di ricerca per l'innovazione cardiovascolare della Cleveland Clinic, ha sviluppato un sistema di intelligenza artificiale (IA) in grado di interpretare alcuni degli esami cardiaci più complessi in ambito medico, le risonanze magnetiche cardiache, senza la necessità di utilizzare dati di addestramento etichettati manualmente. Il nuovo sistema, chiamato CMR-CLIP, è sta...
-
Carnegie Mellon University und Cleveland Clinic entwickeln KI-System für die präzisere Interpretation von MRT-Aufnahmen des Herzens
PITTSBURGH & CLEVELAND--(BUSINESS WIRE)--Ein Forscherteam der Carnegie Mellon University hat in Zusammenarbeit mit dem Cardiovascular Innovation Research Center der Cleveland Clinic ein System künstlicher Intelligenz (KI) entwickelt, das in der Lage ist, einige der komplexesten medizinischen Aufnahmen des Herzens, kardiale Magnetresonanztomographie (MRT), zu interpretieren, ohne dass manuell gekennzeichnete Trainingsdaten erforderlich wären. Das neue System CMR-CLIP interpretiert MRT-Aufnahmen...
-
L'université Carnegie Mellon et la Cleveland Clinic développent un système d'IA dédié à une interprétation encore plus précise des IRM cardiaques
PITTSBURGH et CLEVELAND--(BUSINESS WIRE)--Une équipe de chercheurs de l'université Carnegie Mellon , en collaboration avec le le Centre de recherche sur l'innovation cardiovasculaire de la Cleveland Clinic, a développé un système d'intelligence artificielle (IA) capable d'interpréter certains des examens cardiaques les plus complexes en médecine, comme l'imagerie par résonance magnétique (IRM) cardiaque, sans nécessiter de données d'apprentissage étiquetées manuellement. Ce nouveau système, bap...
-
Resumen: La Universidad Carnegie Mellon y la Cleveland Clinic desarrollan un sistema de IA para interpretar con mayor precisión resonancias magnéticas cardíacas
PITTSBURGH y CLEVELAND--(BUSINESS WIRE)--Un equipo de investigadores de la Universidad Carnegie Mellon, en colaboración con el Centro de Investigación de Innovación Cardiovascular de la Cleveland Clinic, ha desarrollado un sistema de inteligencia artificial (IA) capaz de interpretar una de las exploraciones del corazón más complejas en medicina, las imágenes por resonancia magnética (IRM) cardíacas, sin necesidad de datos de entrenamiento etiquetados manualmente. El nuevo sistema, llamado CMR-C...
-
Artera Presents Multiple ASCO 2026 Abstracts on Multimodal AI (MMAI) Risk Stratification and Treatment Decisions in Cancer
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present multiple abstracts at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29–June 2, 2026, in Chicago. Two breast cancer abstracts demonstrate the performance of Artera’s MMAI across clinically challenging settings. One study assesses prognosis and chemotherapy benefit stratification in node‑positive HR+ breast cancer...
-
Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations
BARCELONA, Spain & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East...
-
Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), today announced that the company will participate at the William Blair 46th Annual Growth Stock Conference. Joseph DeVivo, President, Chief Executive Officer & Chairman and John Doherty, EVP, Chief Financial Officer will participate in a presentation breakout session at 8:40 AM CT on June 4, 2026, and host one-on-one investor meetings throughout the day. A webcast of the presentation will be a...
-
STAAR Surgical Announces Participation in Upcoming Investor Conferences
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. Webcas...
